| |
| |
|
| Insider
Information: |
Crooke Stanley T |
| Relationship: |
Director, 10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,021 |
|
|
Indirect Shares
|
7,547,002 |
|
|
| Direct
Value |
$75,929 |
|
|
|
Indirect Value
|
$34,834,505 |
|
|
| Total
Shares |
7,549,023 |
|
|
| Total
Value |
$34,910,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Exec Chairman of the B... |
2021-01-26 |
2,021 |
2021-01-26 |
497,502 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
7,049,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
463 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 13 of 19
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-09-21 |
4 |
AS |
$35.50 |
$710,000 |
D/D |
(20,000) |
25,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-09-21 |
4 |
OE |
$10.29 |
$205,800 |
D/D |
20,000 |
45,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-09-27 |
4 |
OE |
$10.29 |
$205,800 |
D/D |
20,000 |
45,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-09-27 |
4 |
AS |
$36.05 |
$72,100 |
I/I |
(2,000) |
2,170 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-09-27 |
4 |
OE |
$10.29 |
$20,580 |
I/I |
2,000 |
4,170 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-09-27 |
4 |
AS |
$36.02 |
$720,400 |
D/D |
(20,000) |
25,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-10-05 |
4 |
AS |
$36.61 |
$366,100 |
D/D |
(10,000) |
25,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-10-05 |
4 |
OE |
$10.29 |
$102,900 |
D/D |
10,000 |
35,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-10-05 |
4 |
AS |
$36.61 |
$36,610 |
I/I |
(1,000) |
2,170 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-10-05 |
4 |
OE |
$10.29 |
$10,290 |
I/I |
1,000 |
3,170 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-11-09 |
4 |
AS |
$35.10 |
$72,350 |
I/I |
(2,000) |
2,170 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-11-09 |
4 |
OE |
$10.29 |
$20,580 |
I/I |
2,000 |
3,170 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-11-09 |
4 |
AS |
$35.55 |
$727,996 |
D/D |
(20,000) |
25,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-11-09 |
4 |
OE |
$7.25 |
$194,427 |
D/D |
20,000 |
28,770 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-11-10 |
4 |
AS |
$42.22 |
$42,220 |
I/I |
(1,000) |
2,170 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-11-10 |
4 |
OE |
$10.29 |
$10,290 |
I/I |
1,000 |
3,170 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-11-10 |
4 |
AS |
$40.23 |
$402,300 |
D/D |
(10,000) |
25,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2016-11-10 |
4 |
OE |
$7.25 |
$72,500 |
D/D |
10,000 |
35,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-01-03 |
4 |
OE |
$7.25 |
$72,500 |
D/D |
10,000 |
30,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-01-03 |
4 |
AS |
$47.30 |
$48,050 |
I/I |
(1,000) |
2,170 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-01-03 |
4 |
OE |
$10.29 |
$10,290 |
I/I |
1,000 |
2,670 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-01-03 |
4 |
AS |
$47.30 |
$480,500 |
D/D |
(10,000) |
25,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-01-04 |
4 |
AS |
$50.10 |
$350,700 |
D/D |
(7,000) |
25,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-01-04 |
4 |
OE |
$7.25 |
$50,750 |
D/D |
7,000 |
32,029 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-01-04 |
4 |
AS |
$50.10 |
$35,070 |
I/I |
(700) |
2,170 |
0 |
- |
|
463 Records found
|
|
Page 13 of 19 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
